Category: Expertise


Challenging Impella-supported Protected PCI Cases

State of the Art Approach for Optimizing Patients Prior to TAVR Dr. Siddharth Wayangankar discusses his protected PCI strategy for managing patients with severe aortic stenosis and low EF with multivessel disease, specifically difficult to stent distal left main lesions. “The bottom line is that these patients need complete revascularization before considering TAVR,” he tells … Continue reading “Challenging Impella-supported Protected PCI Cases”

Identifying Cardiogenic Shock Early with a Heart Team Approach

Dr. Alexander Truesdell, Interventional Cardiologist at Inova Heart and Vascular Institute discusses his editorial, the War on Shock, published in the Journal of Invasive Cardiology. The editorial compares his experience as a military physician with his experience as a cardiologist treating cardiogenic shock. Watch the video to learn which systems of care Dr. Truesdell suggests … Continue reading “Identifying Cardiogenic Shock Early with a Heart Team Approach”

PCI vs CABG in Patients with Unprotected Left Main Coronary Artery Disease

Key Takeaways

  • This meta-analysis evaluated 6 randomized controlled trials to determine outcome differences between percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) among patients with unprotected left main coronary artery disease ([ULMCAD] n = 4686).
  • Compared with CABG, PCI correlated with significantly lower rates of 30-day stroke (P = 0.007), death or MI (P = 0.04), or all-cause death, MI, or stroke (P = 0.01).
  • In the PCI group, there was a significantly lower rate of 30-day stroke incidence (P = 0.007) and all-cause death, MI, or stroke (P = 0.01).
  • The authors found no significant difference in outcomes at long-term follow-up (median 39 months) between the two groups.
Reference: Palmerini T et al. Am Heart J. 2017;190:54-63.
Continue readingPCI vs CABG in Patients with Unprotected Left Main Coronary Artery Disease

Specialist Opinion: Updates on Detroit Cardiogenic Shock Initiative with Michael Hacala

Michael Hacala, Detroit Cardiogenic Shock (DCSI) Coordinator at Henry Ford Hospital. Tune in to hear updates about the program, and learn how to participate. Partnering hospital systems participating in DCSI use a defined protocol for early placement of Impella in patients in cardiogenic shock. Since July, initial results from a small sampling of 30 patients … Continue reading “Specialist Opinion: Updates on Detroit Cardiogenic Shock Initiative with Michael Hacala”

Specialist Opinion: Dr. Perwaiz Meraj

Dr. Perwaiz Meraj of Northwell Health discusses a new study demonstrating potential survival with Impella 2.5® heart pump insertion pre-PCI in heart attacks involving the left main coronary artery. IM2-049-17